Market Cap: $42.49B
Market Cap: $42.49B

IQVIA Holdings Inc. ( IQV ) stands at the forefront of the healthcare technology landscape, positioned uniquely to leverage its extensive data capabilities and industry insights. As the global leader…
Charles River Laboratories Initiates Strategic Divestiture to Enhance Core Operations Charles River Laboratories, a key player in the biotechnology and pharmaceutical sectors, announces a significant…
Charles River Laboratories Restructures for Core Focus and Growth In a significant strategic realignment, Charles River Laboratories (NYSE: CRL) announces its plan to divest certain segments of its bu…
AI Revolution: A Shift Toward Practical Applications As the artificial intelligence (AI) landscape undergoes significant transformation, IQVIA Holdings finds itself at the forefront of this evolution.…
IQVIA’s Growth Trajectory: Analysts Recognize Potential in Health Data Solutions In recent developments within the healthcare analytics sector, IQVIA Holdings garners attention as Baird upgrades its r…
IQVIA Holdings Enhances Data Solutions to Support Precision Medicine IQVIA Holdings, a leader in advanced analytics and technology solutions for the healthcare industry, is making significant strides…
IQVIA Holdings: Pioneering Advancements in Healthcare Analytics IQVIA Holdings, a leader in healthcare data analytics, continues to enhance its capabilities in real-world evidence generation, a critic…
IQVIA Holdings: Navigating the Healthcare Sector Amid Market Dynamics As the market experiences fluctuations driven by major tech earnings and macroeconomic developments, IQVIA Holdings stands at the…
IQVIA Holdings Positioned for Strategic Growth Amid Market Dynamics As October comes to a close, IQVIA Holdings stands at the intersection of healthcare innovation and data analytics, capitalizing on…
IQVIA Positioned for Growth Amid Favorable Regulatory Landscape IQVIA Holdings, a leading global provider of advanced analytics and technology solutions for the healthcare sector, finds itself in a fa…
IQVIA Holdings: Navigating a Complex Landscape in Health Data Analytics IQVIA Holdings finds itself at a critical juncture in the health data analytics and technology sector, as analysts present a mix…
Navigating Market Sentiment: The Diverging Views on IQVIA Holdings In recent evaluations, eight analysts offer a mixed perspective on IQVIA Holdings (NYSE:IQV), revealing the complexities of the healt…
IQVIA and Flagship Pioneering Forge Strategic Alliance to Enhance Life Sciences Innovation IQVIA Holdings, a leading global provider of clinical research services and healthcare intelligence, forges a…
IQVIA and Flagship Pioneering Forge Strategic Partnership to Advance Life Sciences IQVIA Holdings, a leading global provider of clinical research services and healthcare intelligence, announces a stra…
Firefly Neuroscience Unveils Groundbreaking EEG Platform to Transform Neurological Assessments Firefly Neuroscience (AIFF) announces the launch of its innovative CLEAR (CLeaning EEG ARtifacts) Platfor…
Innovative EEG Technology Sets New Standard in Neurotechnology Firefly Neuroscience (AIFF) makes a significant leap in neurotechnology with the unveiling of its groundbreaking CLEAR (CLeaning EEG ARti…
Strategic Alliance: IQVIA and Veeva Systems Unite to Transform Healthcare Operations IQVIA Holdings and Veeva Systems have recently forged a significant long-term partnership aimed at enhancing effici…
IQVIA and Veeva Forge Strategic Partnership to Enhance Clinical and Commercial Efficiencies IQVIA Holdings and Veeva Systems announce a transformative long-term partnership aimed at improving operatio…
IQVIA and Veeva Systems Forge Strategic Partnership to Enhance Healthcare Efficiency In a significant development for the healthcare and life sciences sectors, IQVIA Holdings and Veeva Systems have an…
Strategic Alliance to Propel Kexing Biopharm's Global Aspirations Kexing Biopharm, a prominent biopharmaceutical company based in Shenzhen, has recently entered a strategic partnership with IQVIA, a g…
Kexing Biopharm Partners with IQVIA to Enhance Global Drug Development On August 11, 2025, Kexing Biopharm, a prominent biopharmaceutical company based in Shenzhen, announces a strategic partnership w…
IQVIA and Kexing Biopharm Forge Strategic Partnership to Enhance Global Development On August 11, 2025, Kexing Biopharm (688136.SH) and IQVIA (NYSE:IQV) announce a groundbreaking strategic partnership…
IQVIA Holdings: Navigating Mixed Analyst Sentiments in Healthcare Technology IQVIA Holdings Inc. finds itself at a crossroads as analysts express a range of views regarding its future performance. Ove…
IQVIA Holdings Strengthens Market Position with Strong Q2 Results and Revised Guidance In a recent trading session, IQVIA Holdings stands out in the healthcare analytics and technology sector followin…
IQVIA Holdings Prepares for Quarterly Earnings Report Amidst Growth in Life Sciences Sector IQVIA Holdings, a prominent player in the life sciences industry, is set to release its quarterly earnings r…
IQVIA Holdings Poised for Insightful Earnings Report Amid Industry Growth IQVIA Holdings is set to unveil its quarterly earnings report on July 22, 2025, a highly anticipated event that gives stakehol…
IQVIA Holdings Prepares for Key Earnings Report Amid Industry Growth IQVIA Holdings (IQV) is poised to release its quarterly earnings report on July 22, 2025, a significant event that investors and in…
Transforming Healthcare: Avant Technologies Pioneers AI Integration in Patient Care Avant Technologies Inc. is revolutionizing the healthcare landscape by integrating artificial intelligence (AI) with…
Revolutionizing Patient Care Through AI Integration Avant Technologies Inc. is spearheading a transformative movement in healthcare, focusing on the integration of artificial intelligence (AI) within…
Revolutionizing Healthcare: AI Integration in Patient Care Avant Technologies Inc. is making significant strides in transforming healthcare through the integration of artificial intelligence (AI) with…
IQVIA Holdings Faces Surge in Short Interest Amid Market Concerns IQVIA Holdings, a key player in the health data analytics sector, finds itself under scrutiny as short interest in its stock rises sig…
IQVIA Holdings Faces Heightened Short Interest Amid Market Sentiment Concerns IQVIA Holdings, a leader in health data analytics, experiences a notable rise in short interest, with the percentage of sh…
IQVIA Holdings Faces Rising Short Interest Amid Market Sentiment Concerns IQVIA Holdings, a prominent player in the health data analytics sector, is currently experiencing a notable uptick in short in…
Avant Technologies Drives AI Innovations in Healthcare Avant Technologies, Inc. is carving a significant niche in the burgeoning AI healthcare landscape, which is experiencing an unprecedented influx…
Avant Technologies: Pioneering AI Integration in Healthcare Avant Technologies, Inc. emerges as a key player in the burgeoning AI healthcare sector, capitalizing on the increasing venture capital inte…
Avant Technologies Pioneers AI Integration in Healthcare Avant Technologies, Inc. is at the forefront of the integration of artificial intelligence (AI) in healthcare, particularly through its collabo…
Nvidia's Strategic Move to Transform Healthcare through AI Partnerships Nvidia Corp. is making significant strides in the healthcare sector with the announcement of two major partnerships aimed at lev…
Nvidia Expands Healthcare Initiatives Through Strategic Partnerships Nvidia Corp, under the leadership of CEO Jensen Huang, announces two pivotal partnerships aimed at revolutionizing the healthcare s…
Navigating Complexities: IQVIA Holdings and the Adhishthana Cycle IQVIA Holdings, a leader in the healthcare data analytics space, is currently immersed in Phase 18 of its extensive 18-Phase Adhishtha…
IQVIA Holdings: Navigating the Complexity of the Adhishthana Cycle IQVIA Holdings is currently engaged in Phase 18 of its extensive 18-Phase Adhishthana Cycle, a framework designed to analyze and inte…
Navigating the Complexity of Phase 18: IQVIA's Adhishthana Cycle IQVIA Holdings is currently immersed in Phase 18 of its intricate 18-Phase Adhishthana Cycle, a critical framework for understanding th…
IQVIA Holdings Delivers Strong Q1 Performance Against Economic Challenges IQVIA Holdings Inc. reports robust financial results for the first quarter of 2025, showcasing a significant increase in adjus…
IQVIA Holdings Demonstrates Strong Operational Resilience in Q1 2025 IQVIA Holdings Inc. showcases a remarkable financial performance for the first quarter of 2025, reporting an adjusted earnings per…
Navigating Trade Developments: The Strategic Focus for IQVIA Holdings As trade discussions gain momentum, IQVIA Holdings positions itself to capitalize on the evolving landscape within the healthcare…
CleaDeep Launches P1 Range Hood to Combat Cooking Fumes and Health Risks CleaDeep, a leading kitchen appliance manufacturer, recently debuts its P1 range hood series, targeting the alarming health ris…
IQVIA Holdings Prepares for Q4 and Full-Year 2024 Financial Results Announcement IQVIA Holdings Inc. is set to release its financial results for the fourth quarter and full year of 2024 on February 6,…
Digital Health Trends: A New Era of Integration and Personalization The digital health landscape is undergoing a remarkable transformation, as highlighted in the latest report from the IQVIA Institute…
Digital Health Solutions: A Paradigm Shift in Patient Care The IQVIA Institute for Human Data Science releases a compelling report titled "Digital Health Trends 2024: Implications for Research and Pat…
IQVIA Holdings: Driving Healthcare Innovation through Data and Analytics IQVIA Holdings Inc. stands at the forefront of the healthcare and life sciences industries, utilizing its vast resources and ad…
IQVIA Holdings: Pioneering Healthcare Intelligence and Clinical Research IQVIA Holdings Inc., a leader in clinical research and healthcare intelligence, continues to shape the future of medical treatm…